Pandemic influenza: Its origin and control

Microbes and Infection

Volumn 4, Issue 13, 2002, Pages 1309-1316

  Laver, Graeme ^a   Garman, Elspeth ^b  

^a University of Oxford ^*  (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Influenza; Neuraminidase inhibitors; Pandemic

Indexed keywords

ANTIVIRUS AGENT; SIALIDASE; VACCINE;

EPIDEMIC; HUMAN; IMMUNITY; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; BIRDS; CHICKENS; CHINA; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, MOLECULAR; NEURAMINIDASE; ORTHOMYXOVIRIDAE;

INFLUENZA VIRUS;

EID: 0036850862     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00013-8     Document Type: Review

References (41)

1. Smith F.B. The Russian Influenza in the United Kingdom, 1889-1894. Social History of Medicine. 8:1995;55-73.
2. Taubenberger J.K., Reid A.H., Jancewski T.A., Fanning T.G. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Phil. Trans.R. Soc. Lond. B356:2001;1829-1838.
3. Gibbs M.J., Armstrong J.S., Gibbs A.J. Recombination in the haemagglutinin gene of the 1918 "Spanish flu" Science. J. Recombination. 293:2001;1842-1845.
4. Worobey M., Rambaut A., Pybus O.G., Robertson D.L. Questioning the evidence for genetic recombination in the 1918 "Spanish Flu" virus. Science. 296:2002;211a.
5. Center for Disease Control. Mortality and Morbidity Weekly Report. Update: Influenza activity - United States, 2001-02 Season. April 5. 2002.
6. Kawaoka Y., Krauss S., Webster R.G. Avian-to-human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J. Virol. 63:1989;4603-4608.
7. Webster R.G., Laver W.G. Studies on the origin of pandemic influenza 1. Antigenic analysis of A2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits. Virology. 48:1972;433-444.
8. Laver W.G., Webster R.G. Studies on the origin of pandemic influenza 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. Virology. 51:1973;383-391.
9. Ito T., Nelson J., Couceiro S.S., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson K.C., Webster R.G., Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72:1998;7367-7373.
10. Nakajima K., Desselberger U., Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature. 274:1978;334-339.
11. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses in mammals. Science. 293:2001;1773-1775.
12. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 viruses. Science. 298:2001;1840-1842.
13. Deshpande K., Fried V.A., Ando M., Webster R.G. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. USA. 84:1987;36-40.
14. Dowdle W.R. Pandemic influenza: confronting a re-emergent threat. The 1976 experience. J. Infect. Dis. 176:(Suppl. 1):1997;S69-S72.
15. Hirst G.K. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science. 94:1941;22-23.
16. Gottschalk A. The specific enzyme of influenza virus and Vibrio cholerae. Biochim. Biophys. Acta. 23:1957;645-646.
17. Burnet F.M. Quoted. The Australian J. Exp. Biol. and Med. Sci. 26:1948;410.
18. Mayron L.W., Robert B., Winzler R.J., Rafelson M.E. Studies on the neuraminidase of influenza virus. 1. Separation and some properties of the enzyme from Asian and PR8 strains. Arch. Biochem. Biophys. 1:(92):1961;475-483.
19. Noll H., Aoyagi T., Orlando J. The structural relationship of sialidase to the influenza virus surface. Virology. 18:1962;154-157.
20. Laver W.G. The structure of influenza viruses. 2. Disruption of the virus particle and separation of neuraminidase activity. Virology. 20:1963;251-262.
21. Laver W.G., Kilbourne E.D. Identification in a recombinant influenza virus of structural proteins derived from both parents. Virology. 30:1966;493-501.
22. Laver W.G., Valentine R.C. Morphology of the isolated haemagglutinin and neuraminidase subunits of influenza virus. Virology. 38:1969;105-119.
23. Wrigley N.G., Charlwood P.A., Skehel J.J., Brand C.M. The size and shape of influenza virus neuraminidase. Virology. 51:1973;525-529.
24. Seto J.T., Rott R. Functional significance of sialidase during influenza virus multiplication. Virology. 30:1966;731-737.
25. Webster R.G., Laver W.G. Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J. Immunology. 99:1967;49-55.
26. Palese P., Ueda M., Tobita K., Compans R.W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 61:1974;397-410.
27. Seto J.T., Drzeniek R., Rott R. Isolation of a low molecular weight sialidase (neuraminidase) from influenza virus. Biochim. Biophys. Acta. 113:1966;402-404.
28. Laver W.G. Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains. Virology. 86:1978;78-87.
29. Wright C.E., Laver W.G. Preliminary crystallographic data for influenza virus neuraminidase "heads" J. Mol. Biol. 120:1978;133-136.
30. Varghese J.N., Laver W.G., Colman P.M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature. 303:1983;35-40.
31. Wiley D.C. Neuraminidase of influenza virus reveals a flower-like head. Nature. 303:1983;19-20.
32. Colman P.M., Laver W.G., Varghese J.N., Baker A.T., Tulloch P.A., Air G.M., Webster R.G. Three dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature. 326:1987;358-363.
33. Air G.M., Laver W.G. The neuraminidase of influenza virus. Proteins. 6:1989;341-356.
34. Palese P., Schulman J.N., Bodo G., Meindl P. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology. 59:1974;490-498.
35. von Itzstein M., Wu W.-.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Phan T.V., Smythe M.S., White H.F., Oliver S.W., Colman P.M., Varghese J.N., Ryan D.M., Woods J.M., Bethell R.C., Hotham V.J., Cameron J.M., Penn C.R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 363:1993;418-423.
36. Tucker S.P. FLUNET. A new approach for influenza management. 15th International conference on anti-viral research, Prague, March 20:2002.
37. Kim C.U., Williams M.A., Lui H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Amer. Chem. Soc. 119:1997;681-690.
38. Babu Y.S., Chand P., Banta S., Kotian P., Dehghani A., El-Katan Y., Lin T.S., Hutchison T.L., Elliot A.L., Parker C.D., Ananth S.L., Horn L.I., Laver W.G., Montgomery J.A. BCX-1812 (RWJ-27021). Discovery of a novel, highly potent, orally active and selective influenza virus neuraminidase inhibitor through structure-based drug design. J. Medicinal Chemistry. 43:2000;3482-3486.
39. Kati W.M., Montgomery D., Maring C., Stoll V.S., Giranda V., Chen X., Laver W.G., Kohlbrenner W., Norbeck D.W. Novel α- and β-amino acid inhibitors of influenza virus neuraminidase. Antimicrob. Agents Chemother. 45:2001;2563-2570.
40. Roberts N.A. Treatment of influenza with neuraminidase inhibitors: virologic implications. Phil. Trans. Royal Soc. Lond. B356:2001;1893-1895.
41. Fanning T.G., Slemons R.D., Reid A.H., Janczewski T.A., Dean J., Tauenberger J. 1917 avian influenza sequences suggest the 1918 pandemic virus did not acquire its hemagglutinin directly from birds. J. Virol. 76:2002;7860-7862.